Skip to content
Screener

Teleflex TFX Financing Cash Flow

Financing Cash Flow at other companies

Haemonetics logo
HaemoneticsHAE
-$51.53M-2,010%
Utah Medical Products logo
Utah Medical ProductsUTMD
-$1.12M+73.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%
ICU Medical logo
ICU MedicalICUI
-$50.24M+74.2%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%
ITG
Integer HoldingsITGR
$3.83M-97.5%

Other financials

Income statement

See full
Revenue$570.3M+28.9%
Gross profit$331.7M+24.8%
Operating income$72.8M-20.1%
Net income$99.7M-18.7%
EPS (diluted)$2.28-17.7%

Balance sheet

See full
Cash & equivalents$316.9M+23.5%
Total debt$3.0B+49.5%
Total equity$2.9B-31.5%
Total assets$6.8B-8.0%

Cash flow

See full
Operating cash flow$91.9M+348%
CapEx$14.0M-49.5%
Free cash flow$77.9M+220%

Valuation

See full
Market cap$6.15B+24.1%
Enterprise value$8.81B+31.7%
P/S2.7×-0.1×

Profitability

See full
Gross margin46.7%-4.5pp
Operating margin2%-14.9pp
Net margin-45.8%-56.9pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.9%-33.2pp
Debt / equity+0.6×
Current ratio2.6×+0.2×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Teleflex’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 3:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000096943-26-000095
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 29, 2025
Payments for contingent consideration(107)(112)
Dividends paid(29,830)(30,218)
Debt issuance and amendment fees(13,981)(2,800)
Net cash used in financing activities from continuing operations(126,985)(83,192)
Cash flows from discontinued operations:
Net cash provided by operating activities4,79690,131
Net cash used in investing activities(18,144)(12,718)
Net cash (used in) provided by discontinued operations(13,348)77,413

Item 1. Financial Statements (Unaudited):

FAQ

What is Teleflex's financing cash flow?
Teleflex (TFX) reported financing cash flow of -$82M in Q2 2026.
How has Teleflex's financing cash flow changed year-over-year?
Teleflex's financing cash flow decreased by 246.5% year-over-year, from -$23.67M to -$82M.
What is the long-term trend for Teleflex's financing cash flow?
Over 3 years (2021 to 2024), Teleflex's financing cash flow has grown at a -16.2% compound annual growth rate (CAGR), from -$715.82M to -$421.93M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Teleflex's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude